From: Explaining variation in the uptake of HPV vaccination in England
 | Communalities | PC1 | PC2 | PC3 | PC4 |
---|---|---|---|---|---|
Deprivation | Â | Â | Â | Â | Â |
   Average IMD score | 0.96 |  | 0.94 |  |  |
   Average rank | 0.94 |  | 0.92 |  |  |
   Extent, % | 0.93 |  | 0.93 |  |  |
   Local concentration | 0.83 |  | 0.90 |  |  |
Cervical screening, ages 25-49 year | 0.74 | 0.43 | Â | 0.55 | Â |
Childhood immunisation | Â | Â | Â | Â | Â |
   DT/IPV, age 5 | 0.82 | 0.83 |  |  |  |
   DTaP/IPV, age 5 | 0.88 | 0.89 |  |  |  |
   MMR1, age 5 | 0.89 | 0.92 |  |  |  |
   MMR2, age 5 | 0.89 | 0.91 |  |  |  |
   DTaP/IPV/Hib, age 2 | 0.85 | 0.89 |  |  |  |
   MMR, age 2 | 0.87 | 0.92 |  |  |  |
   MenC, age 2 | 0.74 | 0.83 |  |  |  |
Chlamydia: positive test results | 0.65 | Â | 0.55 | 0.56 | Â |
Ethnic composition | Â | Â | Â | Â | Â |
   White | 0.93 | 0.42 |  | 0.81 |  |
   Asian | 0.82 |  |  | -0.85 |  |
   Black | 0.79 | -0.67 |  | -0.51 |  |
   Other | 0.74 | -0.50 |  | -0.62 |  |
QOF scores | Â | Â | Â | Â | Â |
   QOF Clinical | 0.58 |  |  |  | 0.61 |
   QOF Organisation | 0.83 |  |  |  | 0.91 |
   QOF Patient experience | 0.66 |  |  |  | 0.73 |
   QOF Additional services | 0.84 |  |  |  | 0.76 |
% of variance explained | Â | 32.7 | 19.9 | 15.4 | 13.9 |